The purpose of this discussion paper is to help stakeholders understand and consider the issues when developing a new generation medicines policy, so that it is fit for the future.
- Stakeholder collaboration to design a strategy that serves triple aim objectives for all New Zealanders
- Publish forecasts based on analysis of science and expected innovations
- Health Minister (with Research, Science and Innovation Minister) set the budget
- Legislative change to explicitly broaden the definition of health outcomes